Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis

Gastrointestinal Endoscopy

Volumn 70, Issue 4, 2009, Pages 623-631

  Pohl, Heiko ^a   Sonnenberg, Amnon ^a   Strobel, Sebastian ^a   Eckardt, Alexander ^a   Rösch, Thomas ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INVASION; CANCER RECURRENCE; CASE REPORT; COST EFFECTIVENESS ANALYSIS; EARLY CANCER; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; MALE; MEDICAL DECISION MAKING; METAPLASIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RECURRENCE RISK; SENSITIVITY ANALYSIS; SUBMUCOSA; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CATHETER ABLATION; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; MALE; MUCOUS MEMBRANE; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 70349442543     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.11.047     Document Type: Article

References (60)

1. Giovannini M., Bories E., Pesenti C., et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer: preliminary results in 21 patients. Endoscopy 36 (2004) 782-787
2. Larghi A., Lightdale C.J., Ross A.S., et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 39 (2007) 1086-1091
3. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
4. Rosch T. BARRx for total Barrett's eradication: the new super weapon?. Endoscopy 40 (2008) 393-394
5. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
6. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 68 (2008) 35-40
7. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 68 (2008) 867-876
8. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 40 (2008) 370-379
9. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 40 (2008) 359-369
10. Westerterp M., Koppert L.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446 (2005) 497-504
11. Bollschweiler E., Baldus S.E., Schroder W., et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38 (2006) 149-156
12. Vieth M., and Rosch T. Endoscopic mucosal resection and the risk of lymph-node metastases: indications revisited?. Endoscopy 38 (2006) 175-179
13. Yoshinaga S., Gotoda T., Kusano C., et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 67 (2008) 202-209
14. Ishigami S., Natsugoe S., Hokita S., et al. Carcinomatous lymphatic invasion in early gastric cancer invading into the submucosa. Ann Surg Oncol 6 (1999) 286-289
15. Abe N., Sugiyama M., Masaki T., et al. Predictive factors for lymph node metastasis of differentiated submucosally invasive gastric cancer. Gastrointest Endosc 60 (2004) 242-245
16. Tajima Y., Nakanishi Y., Ochiai A., et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 88 (2000) 1285-1293
17. Sharma V.K., Kim H.J., Das A., et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 40 (2008) 380-387
18. Hernandez J.C., Reicher S., Chung D., et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 40 (2008) 388-392
19. Sharma P., Wani S., Weston A.P., et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 55 (2006) 1233-1239
20. Shaheen N.J., Sharma P., Overholt B.F., et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett's esophagus containing dysplasia: interim results of the AIM Dysplasia Trial. Gastroenterology 134 (2008) A-37
21. Inoue H. Endoscopic mucosal resection for esophageal and gastric mucosal cancers. Can J Gastroenterol 12 (1998) 355-359
22. Katada C., Muto M., Manabe T., et al. Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 57 (2003) 165-169
23. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14 (2002) 1085-1091
24. Shimizu Y., Tsukagoshi H., Fujita M., et al. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 56 (2002) 387-390
25. Soehendra N., Seewald S., Groth S., et al. Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). Gastrointest Endosc 63 (2006) 847-852
26. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65 (2007) 3-10
27. Seewald S., Akaraviputh T., Seitz U., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57 (2003) 854-859
28. Peters F.P., Kara M.A., Rosmolen W.D., et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101 (2006) 1449-1457
29. Pouw R.E., Seewald S., Gondrie J.J., et al. Stepwise radical endoscopic resection for complete removal of Barrett esophagus with early neoplasia: an international multicenter study. Gut 40 (2008) A95
30. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
31. Ruol A., Merigliano S., Baldan N., et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 10 (1997) 190-195
32. Stein H.J., Feith M., Mueller J., et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 232 (2000) 733-742
33. Chang A.C., Ji H., Birkmeyer N.J., et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85 (2008) 424-429
34. Dimick J.B., Cowan Jr. J.A., Ailawadi G., et al. National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg 138 (2003) 1305-1309
35. Jamieson G.G., Mathew G., Ludemann R., et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 91 (2004) 943-947
36. Headrick J.R., Nichols III F.C., Miller D.L., et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 73 (2002) 1697-1702
37. Orringer M.B., Marshall B., Chang A.C., et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246 (2007) 363-372
38. Provenzale D., Kemp J.A., Arora S., et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 89 (1994) 670-680
39. Blazeby J.M., Farndon J.R., Donovan J., et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88 (2000) 1781-1787
40. Gerson L.B., Robbins A.S., Garber A., et al. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Am J Gastroenterol 95 (2000) 395-407
41. Rice T.W., Blackstone E.H., Goldblum J.R., et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 122 (2001) 1077-1090
42. van Sandick J.W., van Lanschot J.J., ten Kate F.J., et al. Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg 194 (2002) 28-36
43. Manner H., May A., Pech O., et al. Are patients with "low risk" submucosal invasion of early Barrett's carcinoma eligible for curative endoscopic therapy? Outcomes of endoscopic therapy and surgery in 80 patients with suspected or definite diagnosis of submucosal Barrett's cancer. Gastrointest Endosc 67 (2008) AB75-AB76
44. Centers for Medicare and Medicaid Services. Healthcare Common Procedure Code, pricing information. http://www.cms.hhs.gov/pfslookup/02_PFSsearch.asp. 2008.
45. United States Department of Health and Human Services. National and state statistics on hospital stays by payer. http://hcupnet.ahrq.gov/HCUPnet.jsp. 2006.
46. National average DRG payment. Federal Register Vol. 71, No. 189, September 29, 2006. www.eesedu.com/dtcf/st/06-1695_2007_GERD.pdf. 2007.
47. Shaheen N.J., Inadomi J.M., Overholt B.F., et al. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 53 (2004) 1736-1744
48. Hur C., Nishioka N.S., and Gazelle G.S. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 48 (2003) 1273-1283
49. Vij R., Triadafilopoulos G., Owens D.K., et al. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 60 (2004) 739-756
50. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 (2005) 24-30
51. Buskens C.J., Westerterp M., Lagarde S.M., et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60 (2004) 703-710
52. Vazquez-Sequeiros E., Levy M.J., Clain J.E., et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc 63 (2006) 204-211
53. Zuccaro Jr. G., Rice T.W., Vargo J.J., et al. Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 100 (2005) 601-606
54. Pech O., May A., Gunter E., et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Am J Gastroenterol 101 (2006) 2223-2229
55. Chemaly M., Scalone O., Durivage G., et al. Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy 40 (2008) 2-6
56. May A., Gunter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 53 (2004) 634-640
57. Hull M.J., Mino-Kenudson M., Nishioka N.S., et al. Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol 30 (2006) 114-118
58. Maish M.S., and DeMeester S.R. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 78 (2004) 1777-1782
59. Larghi A., and Waxman I. Endoscopic mucosal resection: treatment of neoplasia. Gastrointest Endosc Clin N Am 15 (2005) 431-454 viii
60. Sibille A., Lambert R., Souquet J.C., et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 108 (1995) 337-344